News from IVAC

November 2019

Event: 10 Years of Progress in Global Immunization Programs

Join us to celebrate progress made over the past decade as tens of millions of children around the world gained access to life-saving vaccines against Hib, pneumococcal, and rotavirus disease. Speakers will also highlight the need to do more in the next ten years to sustain momentum—realize optimal access to currently available vaccines for people […]

Read More >
September 2019

3 Things We Know About Vaccines in a Climate Change Future

Climate change ranks among the WHO’s top 10 threats for 2019—a dubious honor indicating not only its potential effects on human health and vulnerable populations. How will vaccine-preventable diseases be affected by climate change, and what can we in the global immunization field do to mitigate those consequences?

Read More >
August 2019

Four takeaways from iHEA 2019, a Swiss summit on health economics

Last month, representatives from the IVAC Economics and Finance (E&F) team attended the International Health Economics Association (iHEA) Congress in Basel, Switzerland. As new members of Immunization Economics, a specialized group of economists working on immunization, Bryan Patenaude, Cristina Garcia, Gatien de Broucker, and Elizabeth (Libby) Watts had several significant contributions to the biannual conference. […]

Read More >
June 2019

IVAC-led PERCH study reveals viruses as new leading cause of global childhood pneumonia

Respiratory syncytial virus (RSV) and other viruses now appear to be the main causes of severe childhood pneumonia in low- and middle-income countries, highlighting the need for vaccines against these pathogens, according to a study from a consortium of scientists from around the world led by the International Vaccine Access Center in the Johns Hopkins Bloomberg School of Public Health.

Read More >
female adult
April 2019

Life-course immunization: Building the consensus for adult vaccination

By Lois Privor-Dumm Vaccines are an essential part of the care of babies and children, offering protection from diseases like diphtheria, tetanus, pneumonia, and polio, diseases that once harmed or killed thousands of U.S. children every year and that still kill thousands around the world. Sometimes forgotten is that adults can also benefit from vaccines. […]

Read More >
February 2019

Dr. Naor Bar-Zeev appointed as the new deputy director of IVAC

The International Vaccine Access Center (IVAC) is pleased to announce that Naor Bar-Zeev, MBBS(Hons), MPH, MBiostat, PhD, has been appointed as the new deputy director of IVAC. Naor joined the IVAC team in 2017 as an Associate Professor in the Department of International Health at the Johns Hopkins Bloomberg School of Public Health.

Read More >